Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis-Reference-Cited by-同舟云学术

Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis

Published:2022-06 Issue: Volume:131 Page:155196
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Nguyen Nam Nhat,Ho Dung Si,Nguyen Hung Song,Ho Dang Khanh Ngan,Li Hung-Yuan,Lin Chia-Yuan,Chiu Hsiao-Yean,Chen Yang-Ching

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference98 articles.

1. WHO n.d. Coronavirus disease (COVID-19) pandemic. Updated November 23. Accessed November 30, 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

2. The clinical characteristics and risk factors of severe COVID-19;Hu;Gerontology,2021

3. COVID-19 and diabetes mellitus: from pathophysiology to clinical management;Lim;Nat Rev Endocrinol,2021

4. DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: a meta-analysis;Yang;PLoS One,2021

5. The association between anti-diabetic agents and clinical outcomes of COVID-19 in patients with diabetes: a systematic review and meta-analysis;Han;Arch Med Res,2021

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Factors of Worse Prognosis in COVID-19: Results from a Cross-sectional Study on 52 Inpatients Admitted to the Internal Medicine Department;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-08

2. Impact of Antidiabetic Drugs on Clinical Outcomes of COVID-19: A Nationwide Population-Based Study;Endocrinology and Metabolism;2024-06-30

3. Metformin alleviates inflammatory response and severity rate of COVID-19 infection in elderly individuals;Translational Medicine of Aging;2024-06

4. Prevalence, Predictors, and Outcomes of Type 2 NSTEMI in Hospitalized Patients With COVID‐19;Journal of the American Heart Association;2024-05-21

5. Impact of the COVID-19 pandemic on antidiabetic drugs initiation in Sweden, an interrupted time series study;2024-05-10